Deep Reasoning Engine: Multi-Framework Thinking Prompt

Problem: Should our 12-person SaaS startup raise a Series A now or wait 18 months? Output format: executive brief. Domain: B2B SaaS, $800K ARR, 15% MoM growth.

REFRAME: The core question isn't 'raise or wait' — it's 'at what valuation and dilution does capital accelerate growth faster than organic compounding?' Hidden assumption: that raising is binary. It isn't. FIRST PRINCIPLES: At $800K ARR with 15% MoM, you'll hit ~$4.8M ARR in 18 months without capital. Series A typically prices at 8-12x ARR. Today: ~$6-10M valuation. In 18 months: ~$38-58M. Dilution cost of raising now vs. later: ~25-35% of your equity value. STEELMAN FOR RAISING NOW: Market windows close. A key competitor could raise and lock up distribution channels. Top GTM hires get expensive. Capital buys optionality when you have momentum — not when you need it. STEELMAN FOR WAITING: You haven't proven enterprise ACV expansion yet. Raising on product-market-fit signals without repeatable sales motion means you'll burn runway figuring out what you should have learned cheaply. DEVIL'S ADVOCATE: The 15% MoM figure — is it new logos or expansion revenue? If expansion, your new logo engine may be weaker than it looks. That changes the Series A narrative significantly. VERDICT (Medium-High confidence): Wait 6-9 months, not 18. Use the window to close 3 enterprise reference customers and document your sales playbook. Then raise on a proven motion, not just growth rate. Exception: if a strategic lead investor approaches now, take the meeting. KNOWLEDGE GAPS: Net Revenue Retention rate, payback period on CAC, pipeline coverage ratio. Get these before any investor conversation.